Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
Submitted by
admin
on October 31, 2009 - 11:39am
Source:
PR NewsWire
News Tags:
Eisai
Eribulin
breast cancer
Headline:
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
Do Not Allow Advertisers to Use My Personal information
